Why Baby Bunting, Carsales, GWA, and Imugene shares are racing higher

These ASX shares are starting the week strongly.

| More on:
An investor sits at her desk and stretches her arms above her head in delight.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to start the week with a disappointing decline. The benchmark index is currently down 0.9% to 7,272.1 points.

Four ASX shares that are not letting that hold them back are listed below. Here's why they are rising:

Baby Bunting Group Ltd (ASX: BBN)

The Baby Bunting share price is up 9% to $2.28. Investors have been buying this baby products retailer's shares after analysts at Morgans upgraded them to an add rating with a $2.50 price target. The broker made the move after increasing its earnings estimates to reflect cost reductions and a better sales outlook.

Carsales.Com Ltd (ASX: CAR)

The Carsales share price is up 6% to $26.11. This follows the release of the auto listings company's FY 2023 results. Carsales reported an 18% increase in pro forma revenue and a 43% lift in adjusted net profit after tax to $278.2 million. Looking ahead, management expects "to deliver good growth in Revenue and [pro forma] EBITDA in FY24" and an "expansion in the carsales Group EBITDA margin."

GWA Group Ltd (ASX: GWA)

The GWA share price is up 7% to $2.06. This has been driven by the release of the building fittings company's full-year results. GWA reported a 22.7% increase in statutory net profit to $43.2 million. Management commented: "GWA delivered a solid result for FY23 within a rapidly evolving operating environment that comprised two distinct halves."

Imugene Limited (ASX: IMU)

The Imugene share price is up 3.5% to 9.2 cents. This morning, this immuno-oncology company announced that its Phase 1 MAST (metastatic advanced solid tumours) trial evaluating the safety of novel cancer-killing virus CF33- hNIS (VAXINIA) has cleared the cohort 3 intratumoral (IT) arm of the monotherapy dose escalation study.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Carsales.com. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

A young woman holding her phone smiles broadly and looks excited, after receiving good news.
Share Gainers

Why 4DMedical, Regis Resources, Unico Silver, and WiseTech Global shares are pushing higher

These shares are having a good time on hump day. But why?

Read more »

A mature-aged woman wearing goggles and a red cape, rides her bike along the beach looking victorious.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a tough Tuesday for investors.

Read more »

Woman with an amazed expression has her hands and arms out with a laptop in front of her.
Share Gainers

Why BlueScope, DroneShield, Monadelphous, and SGH shares are racing higher today

These shares are outperforming on Tuesday. But why?

Read more »

Man looking at digital holograms of graphs, charts, and data.
Share Gainers

Top 5 ASX 200 tech shares for growth in 2025

It was a rollercoaster year for ASX 200 tech shares, with fears of an AI bubble sending them into a bear…

Read more »

Ten happy friends leaping in the air outdoors.
Share Gainers

Here are the top 10 ASX 200 shares today

The ASX had a lukewarm start to the week today.

Read more »

A young woman raises her arm in celebration against a backdrop of brightly coloured fireworks in the sky.
Share Gainers

Buying ASX uranium shares like Paladin Energy? Here's why they're starting 2026 with a bang!

Investors are piling into ASX uranium stocks in these early days of 2026. But why?

Read more »

Three happy office workers cheer as they read about good financial news on a laptop.
Share Gainers

Why Civmec, Fenix, Paladin Energy, and Vulcan Steel shares are pushing higher today

These shares are starting the week on a positive note.

Read more »

Ecstatic woman looking at her phone outside with her fist pumped.
Share Gainers

Why 4DMedical, Elsight, Judo, and Nickel Industries shares are pushing higher today

These shares are starting the year in a positive fashion. But why?

Read more »